#1 Clinical Trials Search in Europe

PAPAVERINE HYDROCHLORIDE

Papaverine hydrochloride is a versatile smooth muscle relaxant that has been studied in various clinical settings. As an opium alkaloid antispasmodic drug, it works by directly affecting smooth muscle, reducing spasm and promoting relaxation. The drug has a relatively short half-life of 0.5-2 hours, with effects becoming apparent within 10 minutes of administration. This article explores the various applications of papaverine hydrochloride in clinical trials, ranging from labor induction and cervical ripening to treating arterial spasm and potentially enhancing cancer treatments. Understanding how this medication is being investigated can provide valuable insights into its potential benefits and emerging therapeutic applications.

Table of Contents

What is Papaverine Hydrochloride?

Papaverine Hydrochloride is a medication classified as a smooth muscle relaxant, also known as an antispasmodic drug. It is derived from opium but does not have the same pain-relieving (analgesic) or addictive properties as opioids. Instead, it works directly on smooth muscle tissue, causing it to relax[1]. The drug was first isolated from the opium poppy plant and has been used in medicine for many decades.

Papaverine is sometimes referred to by other names including Cerebid, Cerespan, Pavabid, Pavacap, and several other brand names depending on the country and manufacturer[13].

How Papaverine Works

Papaverine works through a specific mechanism that directly affects smooth muscle cells. It is classified as a musculotropic antispasmodic drug, meaning it targets and acts directly on the muscle tissue rather than on the nerves that control the muscles[1].

Specifically, papaverine is a phosphodiesterase (PDE) inhibitor, particularly targeting PDE10. By inhibiting this enzyme, papaverine increases the levels of certain cellular messengers that lead to smooth muscle relaxation[5]. This relaxation effect makes it useful for treating conditions where muscle spasm or constriction is problematic.

Research has shown that papaverine has a relatively short half-life of 0.5-2 hours, meaning it is cleared from the body fairly quickly. Its effects typically begin within 10 minutes after administration[1][2].

Medical Uses of Papaverine

Papaverine hydrochloride has a variety of medical applications due to its ability to relax smooth muscle. It is used in several different medical specialties to treat conditions where muscle spasm or constriction is a problem. Clinical trials are investigating its use in numerous medical conditions[1][3].

The drug has both established uses and emerging applications being studied in clinical trials. Some of the key medical uses include:

  • Facilitating labor induction and childbirth
  • Preventing and treating vascular spasms during medical procedures
  • Treatment component for erectile dysfunction
  • Potential adjunct therapy in cancer treatment
  • Management of urinary stones and related pain
  • Possible treatment for cognitive deficits in certain conditions

Papaverine in Labor Induction and Childbirth

Papaverine has shown promise in labor induction and childbirth procedures. The cervix consists of connective tissue, smooth muscle, and parasympathetic innervation. Smooth muscle makes up about 15% of the cervix and is mainly found beneath the internal opening of the cervix[1].

In labor induction, papaverine is being studied for its ability to affect cervical ripening. Clinical trials are investigating whether administering papaverine before inserting devices used for cervical ripening (such as balloon catheters or prostaglandin preparations like Propess) can improve outcomes[1][2].

Research indicates several potential benefits of papaverine in labor:

  • It may help increase the Bishop score (a measure of cervical readiness for labor) more effectively than traditional methods alone[1]
  • It could potentially reduce pain during catheter insertion procedures[1]
  • When used with oxytocin, it may reduce the time to active labor compared to oxytocin alone[10]
  • Some studies suggest it might shorten the first stage of labor by relaxing the cervical smooth muscle[1]

One clinical trial is specifically looking at whether combining papaverine with oxytocin can improve labor induction outcomes. The study aims to determine if this combination can reduce the time to active labor and potentially lower the rate of cesarean deliveries[10].

Papaverine in Vascular Procedures

Papaverine is frequently used in vascular procedures to prevent and treat arterial spasms. Due to its direct effect on smooth muscle, it can help maintain the patency (openness) of blood vessels during and after medical procedures[3].

Several clinical trials are investigating papaverine’s use in vascular procedures, including:

  • Radial artery procedures: Papaverine may help prevent radial artery spasm (RAS) during transradial cerebral angiography. RAS is a common complication that can lead to severe pain and is the most frequent cause of transradial angiography failure[3]
  • Peripheral arterial catheter patency: Studies in pediatric patients are examining whether papaverine combined with heparin is more effective than heparin alone in maintaining the patency of peripheral arterial catheters during surgery[4]
  • Radial artery dilation: Research is looking at whether a periradial injection of papaverine before cannulation can increase the diameter of the radial artery, making the procedure easier and reducing the risk of complications[6]
  • Renal artery blood flow: Investigations are underway to determine if papaverine can improve renal artery blood flow after the removal of clamps during robot-assisted partial nephrectomy (kidney surgery)[11]

For patients undergoing vascular procedures, papaverine may help reduce pain and complications by preventing blood vessel spasms. It has shown potential to improve outcomes in various vascular interventions by maintaining adequate blood flow[3][4].

Papaverine in Cancer Treatment

An emerging area of research is the use of papaverine in cancer treatment. Several clinical trials are investigating its potential role as an adjunct to standard cancer therapies, particularly radiation therapy[13][14].

Researchers are studying papaverine’s effects on tumor cells and the tumor environment:

  • Improving radiation effectiveness: Papaverine may help radiation therapy work better by making tumor cells more sensitive to radiation[13]
  • Targeting tumor hypoxia: Cancer cells often exist in low-oxygen (hypoxic) environments, which can make them resistant to treatment. Papaverine may help by increasing oxygen levels in tumors[13]
  • Mitochondrial metabolism inhibition: Some studies are investigating papaverine’s ability to inhibit mitochondrial metabolism in cancer cells, potentially making them more vulnerable to treatment[14]

Clinical trials are currently exploring papaverine’s use in:

  • Non-small cell lung cancer (NSCLC)[14]
  • Locally advanced rectal cancer[13]
  • Lung metastases (cancer that has spread to the lungs)[13]

These studies are in early phases, and more research is needed to fully understand papaverine’s potential role in cancer treatment[13][14].

Papaverine for Erectile Dysfunction

Papaverine has been used in the treatment of erectile dysfunction (ED), particularly before the development of oral medications like sildenafil (Viagra). Its ability to relax smooth muscle makes it effective in improving blood flow to the penis[9].

For ED treatment, papaverine is typically used in the following ways:

  • Intracavernous injections: Papaverine can be injected directly into the penis, often as part of a combination therapy known as “Triplemix” which includes prostaglandin E1 and phentolamine[9]
  • Post-surgical rehabilitation: After prostate surgery, papaverine injections may be used as part of erectile rehabilitation programs to maintain penile tissue health and promote recovery of natural function[9]

Clinical trials have investigated the use of papaverine as part of comprehensive ED management, particularly following radical prostatectomy (surgical removal of the prostate). One study examined whether papaverine, as part of a Triplemix injection therapy, could help patients recover erectile function after nerve-sparing radical prostatectomy[9].

While effective, intracavernous injections of papaverine have largely been replaced by oral medications for first-line ED treatment. However, they remain an important option for patients who don’t respond to or cannot take oral medications[9].

Other Medical Uses

Papaverine has several other medical applications being investigated in clinical trials:

  • Cognitive enhancement: Research is examining whether papaverine, as a PDE10 inhibitor, could help reduce cognitive deficits associated with schizophrenia. Preclinical studies suggest PDE10 inhibitors might improve cognitive function[5]
  • Prostatic hyperplasia: A clinical trial is investigating topical papaverine for the treatment of prostatic hyperplasia (enlarged prostate), which may help with associated urinary symptoms[7]
  • Acute gastroenteritis: Studies are comparing papaverine to other medications for pain relief in acute infectious gastroenteritis in emergency department settings[8]
  • Nerve compression diagnosis: Research is looking at whether papaverine nerve blocks can improve blood flow visualization (the “Phoenix Sign”) to accurately diagnose nerve compression conditions[12]

These diverse applications highlight papaverine’s versatility as a smooth muscle relaxant and its potential benefits across multiple medical specialties[5][7][8].

How Papaverine is Administered

Papaverine can be administered through several different routes, depending on the medical condition being treated[1][3][9]:

  • Intravenous (IV): Directly into a vein, commonly used in labor induction studies and vascular procedures
  • Intracavernous: Injection directly into the penis for erectile dysfunction
  • Perineural: Injection around nerves for diagnostic or therapeutic purposes
  • Periradial: Injection around the radial artery before procedures
  • Topical: Applied to the skin in certain conditions
  • Oral: Taken by mouth, though less common in current clinical practice
  • Subcutaneous: Injected under the skin

The dosage varies based on the condition and administration route. For example:

  • For labor induction studies: 80 mg IV in 100 ml saline[1][2]
  • For radial artery procedures: 30 mg mixed with saline[3]
  • For ED treatment: As part of Triplemix injections, with specific dosing determined by a healthcare provider[9]

Potential Side Effects

As with any medication, papaverine can cause side effects. The specific side effects may vary depending on how the drug is administered and what condition is being treated[1][3].

Potential side effects include:

  • Blood pressure changes, particularly hypotension (low blood pressure)
  • Dizziness or lightheadedness
  • Flushing (reddening of the skin)
  • Headache
  • Gastrointestinal effects like nausea or upset stomach
  • Local reactions at the injection site

When used for erectile dysfunction, additional potential side effects include:

  • Priapism (prolonged erection) requiring medical attention
  • Penile pain or bruising
  • Fibrosis (scarring) with repeated injections

It’s important to note that severe side effects are uncommon when papaverine is used as directed under medical supervision[1][3][9].

Ongoing Research

Papaverine continues to be the subject of significant medical research, with numerous clinical trials investigating its potential in various conditions[1][2][10][13][14].

Current areas of active research include:

  • Labor induction optimization and reducing delivery times
  • Improving outcomes in vascular procedures
  • Cancer treatment, particularly in combination with radiation therapy
  • Cognitive enhancement in neuropsychiatric disorders
  • Novel delivery methods for specific conditions

As research continues, our understanding of papaverine’s potential benefits and optimal uses will likely expand. Patients interested in the latest developments should discuss with their healthcare providers or consider whether participating in a clinical trial might be appropriate for their situation[1][2][13][14].

Application Area Key Clinical Trials Dosage & Administration Potential Benefits Current Status
Labor Induction NCT05759364, NCT06550232, NCT06547437 80 mg IV in 100 ml saline, administered 30 minutes before cervical procedures Improved Bishop score, reduced pain during catheter insertion, potentially shortened labor duration Under investigation in randomized controlled trials
Arterial Spasm Prevention NCT05861765, NCT04030663, NCT03894904 Varies by trial: 30mg/10ml through arterial sheath; periradial injection; 0.12 mg/mL with heparin Prevention of radial artery spasm, maintenance of arterial catheter patency, improved blood flow Multiple trials comparing to placebo or standard treatments
Cancer Treatment NCT03824327, NCT05136846, NCT06834126 IV administration in combination with radiation therapy, specific doses being determined Potential reduction of tumor hypoxia, enhanced effectiveness of radiation therapy Phase I trials determining maximum tolerated dose and safety profile
Cognitive Enhancement NCT01813955 300 mg orally (depot capsule) Potential reduction of cognitive deficits in schizophrenia through PDE10 inhibition Early investigation phase
Urological Applications NCT03064282, NCT00080808 Topical application for prostatic hyperplasia; injection as part of Triplemix for erectile dysfunction Potential treatment for prostatic hyperplasia; help maintain erectile function when used with other medications Preliminary investigations
Renal Function NCT04162834 30 mg mixed with 5 ml normal saline, sprinkled around renal artery Improved renal artery blood flow after declamping during partial nephrectomy Randomized, placebo-controlled study
Gastrointestinal NCT02711241 80 mg by slow IV infusion Potential pain relief in acute gastroenteritis compared to dipyrone Comparative study in emergency department setting
Nerve Function NCT06919289 0.5 cc of papaverine HCL (30 mg/ml) perineural infiltration Improved blood flow after nerve blocks, potential diagnostic and therapeutic applications Pilot study comparing to lidocaine

FAQ

  • What is papaverine hydrochloride and how does it work? Papaverine hydrochloride is an opium alkaloid antispasmodic drug that directly affects smooth muscle. It works by reducing smooth muscle spasm, resulting in relaxation. The drug has a half-life of 0.5-2 hours, and its effects typically begin within 10 minutes after administration. Unlike some other opium derivatives, papaverine primarily acts as a muscle relaxant rather than a pain reliever, though it does have some analgesic properties.
  • How is papaverine hydrochloride being used in labor induction? In labor induction, papaverine hydrochloride is being studied for its ability to relax the smooth muscle of the cervix. Clinical trials are investigating whether administering papaverine before cervical balloon catheter insertion or prostaglandin (Propess) application can improve cervical ripening, reduce pain during the procedure, and potentially shorten labor duration. The drug may help achieve a more favorable Bishop score (a measure of cervical readiness for labor) and improve the induction-to-delivery interval when used alongside other induction methods.
  • Can papaverine hydrochloride help with arterial spasms? Yes, papaverine hydrochloride is being studied for its effectiveness in preventing and treating arterial spasms. Clinical trials are investigating its use in transradial cerebral angiography to prevent radial artery spasm, which is a common complication during this procedure. It's also being tested for application around the renal artery during kidney surgeries and as a periradial injection to increase radial artery diameter before cannulation. The anti-vasospasm properties of papaverine make it potentially valuable in vascular procedures.
  • Is papaverine hydrochloride being investigated for cancer treatment? Yes, papaverine hydrochloride is being studied in cancer treatment, particularly in combination with radiation therapy. Research suggests it may enhance the effectiveness of radiation by targeting mitochondrial metabolism and potentially reducing tumor hypoxia (low oxygen levels in tumors), which can make cancer cells more resistant to radiation. Clinical trials are investigating its use in non-small cell lung cancer and locally advanced rectal cancer in combination with standard treatments. These studies aim to determine the optimal dose and assess whether this combination improves outcomes.
  • What are the potential side effects or risks of papaverine hydrochloride? While specific side effects vary depending on the dose and route of administration, clinical trials are carefully monitoring for adverse events. In various applications, researchers are watching for effects such as changes in blood pressure, systemic hypotension (low blood pressure), complications at injection sites, and any unexpected reactions. The clinical trials include safety monitoring to determine the maximum tolerated dose (MTD) in different contexts and to establish the overall safety profile of papaverine when used for various medical conditions.

Ongoing Clinical Trials on PAPAVERINE HYDROCHLORIDE

  • Study on Sildenafil and Vacuum Erection Device Therapy for Men with Prostate Cancer Undergoing Nerve-Sparing Surgery

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Antispasmodic: A medication that relieves or prevents muscle spasms, particularly those in smooth muscle tissues like the digestive tract, blood vessels, and reproductive organs.
  • Bishop score: A scoring system used to determine how ready the cervix is for labor. It takes into account cervical dilation, effacement, consistency, position, and the station of the baby's head. A higher score indicates a more favorable cervix for labor induction.
  • Blood Oxygen Level Dependent (BOLD) functional MRI: A type of functional MRI that detects changes in blood oxygen levels to measure brain activity or, in cancer research, to evaluate oxygen levels in tumors.
  • Catheter balloon: A medical device inserted into the cervix during labor induction that applies pressure to promote cervical dilation and ripening.
  • Cervical ripening: The process of softening, thinning, and beginning to open the cervix in preparation for labor and delivery.
  • Consolidation chemotherapy: Chemotherapy given after the initial treatment to kill any remaining cancer cells and reduce the risk of recurrence.
  • Dicrotic notch: A feature on an arterial pressure waveform that represents the brief increase in aortic pressure when the aortic valve closes at the beginning of diastole.
  • Dose-escalation study: A clinical trial design where the dose of a drug is gradually increased to find the optimal balance between effectiveness and acceptable side effects.
  • Effacement: The thinning and shortening of the cervix during labor preparation, measured as a percentage.
  • Erectile dysfunction: The inability to achieve or maintain an erection sufficient for satisfactory sexual performance.
  • Induction of labor: The process of artificially stimulating the uterus to start labor using medications or other techniques.
  • Induction-to-delivery interval: The time period from when labor induction begins to when the baby is delivered.
  • Maximum tolerated dose (MTD): The highest dose of a drug that does not cause unacceptable side effects in a clinical trial.
  • Microvascular perfusion: The passage of blood through the smallest blood vessels in the body, providing oxygen and nutrients to tissues.
  • Mitochondrial inhibition: Blocking the function of mitochondria, the energy-producing structures in cells, which can affect cellular metabolism and oxygen consumption.
  • Musculotropic: Having a direct effect on muscle tissue.
  • Nerve grafting: A surgical procedure that involves taking a nerve from one area of the body and using it to repair damaged nerves elsewhere.
  • Oxytocin: A hormone that causes uterine contractions during labor and helps the uterus return to its normal size after delivery.
  • Peripheral arterial catheter: A thin tube inserted into an artery, usually in the arm or leg, to monitor blood pressure or draw blood samples during surgery.
  • Phosphodiesterase (PDE) inhibitor: A class of drugs that block enzymes called phosphodiesterases, affecting various cellular processes. Different types of PDE inhibitors have different effects throughout the body.
  • Propess: A vaginal insert containing prostaglandin E2 (PGE2) used for cervical ripening during labor induction.
  • Prostatic hyperplasia: A non-cancerous enlargement of the prostate gland that can cause urinary symptoms in men.
  • Radial artery spasm (RAS): A sudden contraction of the radial artery (in the wrist) that can occur during medical procedures such as angiography, causing pain and potentially complicating the procedure.
  • Stereotactic Body Radiation Therapy (SBRT): A precise form of radiation therapy that uses special equipment to position the patient and deliver radiation to tumors with high accuracy, requiring fewer treatments than traditional radiation therapy.
  • Total mesorectal excision (TME): A surgical technique for removing rectal cancer along with the surrounding fatty tissue (mesorectum) that contains lymph nodes.
  • Transradial approach: A medical procedure that accesses the heart or blood vessels through the radial artery in the wrist rather than through the femoral artery in the groin.
  • Tumor hypoxia: A condition where tumor tissues have lower oxygen levels than normal tissues, which can make cancer cells more resistant to radiation therapy and some chemotherapy drugs.
  • Visual analogue scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured, such as pain. Patients indicate their perception by marking a position on a continuous line between two end-points.

References

  1. https://clinicaltrials.gov/study/NCT05759364
  2. https://clinicaltrials.gov/study/NCT06550232
  3. https://clinicaltrials.gov/study/NCT05861765
  4. https://clinicaltrials.gov/study/NCT03894904
  5. https://clinicaltrials.gov/study/NCT01813955
  6. https://clinicaltrials.gov/study/NCT04030663
  7. https://clinicaltrials.gov/study/NCT03064282
  8. https://clinicaltrials.gov/study/NCT02711241
  9. https://clinicaltrials.gov/study/NCT00080808
  10. https://clinicaltrials.gov/study/NCT06547437
  11. https://clinicaltrials.gov/study/NCT04162834
  12. https://clinicaltrials.gov/study/NCT06919289
  13. https://clinicaltrials.gov/study/NCT03824327
  14. https://clinicaltrials.gov/study/NCT05136846